Showing results (311-320 of 379) with videos related to

Sort By:
Pageof 38
Annals of the New York Academy of Sciences|April 5, 1997
Analysis of CD40-CD40 ligand interactions in the regulation of human B cell functionP E Lipsky, J F Attrep, A C Grammer, et al.
International Immunology|June 6, 2000
The influence of CD40-CD154 interactions on the expressed human V(H) repertoire: analysis of V(H) genes expressed by individual B cells of a patient with X-linked hyper-IgM syndromeH P Brezinschek, T Dörner, N L Monson, et al.
The Journal of Trauma|August 1, 1995
Alterations in leukocyte adhesion molecule expression after burn injuryF E Nwariaku, W J Mileski, E Lightfoot, et al.
Clinical and Experimental Rheumatology|March 1, 1997
Pleurisy in primary Sjögren's syndrome: T cell receptor beta-chain variable region gene bias and local autoantibody production in the pleural effusionK Kawamata, H Haraoka, S Hirohata, et al.
The Journal of Rheumatology. Supplement|September 1, 1988
Treatment of the seronegative spondyloarthropathies with sulfasalazineS H Zwillich, S S Comer, E Lee, et al.
Arthritis and Rheumatism|January 20, 1998
Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 productionX Tao, H Schulze-Koops, L Ma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytesN Oppenheimer-Marks, L S Davis, D T Bogue, et al.
The Journal of Rheumatology|November 1, 1993
The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8M A Dooley, J J Cush, P E Lipsky, et al.
Arthritis and Rheumatism|March 27, 2001
Immunoglobulin Vkappa light chain gene analysis in patients with Sjögren's syndromeC Heimbächer, A Hansen, A Pruss, et al.
The Journal of Rheumatology|November 18, 1998
Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4H Schulze-Koops, L S Davis, T P Haverty, et al.
Pageof 38